Purpose: Laparoscopic gastrectomy in obese patients has been investigated in several studies, but its feasibility has rarely been examined in morbidly obese patients, such as in those with a body mass index (BMI) of ≥30 kg/m 2 . The present study aimed to evaluate the technical feasibility and safety of laparoscopic gastrectomy in morbidly obese patients with gastric cancer. Materials and Methods: A total of 1,512 gastric cancer patients who underwent laparoscopic distal gastrectomy (LDG) were divided into three groups: normal (BMI<25 kg/m 2 , n=996), obese (BMI 25~30 kg/m 2 , n=471), and morbidly obese (BMI≥30 kg/m 2 , n=45). Short-term surgical outcomes, including the course of hospitalization and postoperative complications, were compared between the three groups. Results: The morbidly obese group had a significantly longer operating time (240 minutes vs. 204 minutes, P=0.010) than the normal group, but no significant differences were found between the groups with respect to intraoperative blood loss or other complications. In the morbidly obese group, the postoperative morbidity and mortality rates were 13.3% and 0%, respectively, and the mean length of hospital stay was 8.2 days, which were not significantly different from those in the normal group. Subgroup analysis showed that postoperative complication rates were not high in morbidly obese patients, independent of the type of anastomosis technique used and level of lymph node dissection. Conclusions: LDG is technically feasible and safe in morbidly obese patients with a BMI of ≥30 kg/m 2 and early gastric carcinoma. Except for a longer operating time, LDG might represent a reasonable treatment option in these patients.
Introduction
In Korea and Japan, the implementation of a nationwide surveillance program for the early detection of gastric carcinoma has resulted in a widespread acceptance of laparoscopic gastrectomy (LG) as a valid alternative to open surgery, for the treatment of early gastric cancer (EGC). 1 Clinical advantages of LG over open surgery, including better cosmesis, less pain, faster bowel recovery, reduced hospital stay, lower morbidity, and improved short-term quality of life, have been reported in several studies. [2] [3] [4] Furthermore, the long term outcomes of LG for EGC are comparable to those of open surgery, with a 5-year survival rate exceeding 98%. 5 Obesity is regarded as a major technical limiting factor for LG, because of the substantial operative difficulties caused by the abundant visceral fat and a narrow operating field. However, increasingly advanced surgeon skills and laparoscopic instrument development have facilitated the conduction of studies designed to address the technical feasibility of LG in obese patients. [6] [7] [8] [9] [10] [11] Although the majority of these studies have concluded that LG is technically fea- . 12, 13 In the present study, we aimed to evaluate the shortterm surgical outcomes of laparoscopic distal gastrectomy (LDG) in morbidly obese patients (BMI of ≥30 kg/m 2 ) with gastric carcinoma.
Materials and Methods
Patients
Between January 2006 and September 2012, 1,532 patients underwent LDG for gastric carcinoma at our institute. Twenty patients who underwent combined surgery because of a concomitant malignancy were excluded, and the remaining 1,512 patients were retrospectively enrolled in the present study. The indication for LDG at our institution was a mucosal or submucosal cancer without lymph node metastasis (cT1N0) which was unsuitable for endoscopic resection. Some patients with advanced gastric cancer (cT2-3N0 or cN1-2) were subjected to laparoscopic surgery only for clinical trial purposes (ClinicalTrials.gov, NCT01088204 
Operative technique
All operations were performed by three experienced surgeons.
Briefly, with the patient in the reverse Trendelenburg position, two operator ports were placed on the patient's right side, two assistant ports on the left, and one umbilical port placed for laparoscope insertion. The liver was retracted upward through an additional 5-mm port placed at the epigastrium or by using a simple suturing technique. Under pneumoperitoneum at an insufflation pressure of 12 to 14 mmHg, the procedure began with the division of the greater omentum, 3 cm from the gastroepiploic vessels, and then moved toward the left gastroepiploic area. Lymph node dissection (LND) was performed as described in the Japanese Classification of Gastric Carcinoma (3rd English edition). 16 In the present study, D1+LND refers to excision of perigastric lymph nodes and number 7, 8a, and 9 lymph nodes, and D2 LND refers to excision of perigastric lymph nodes and number 7, 8a, 9, 11p, and 12a lymph nodes. All gastric and LNDs were performed using LigaSureTM For intracorporeal anastomosis, the Billroth II method, performed using an endoscopic linear stapler, was the primary choice for reconstruction. Intergroup comparisons showed that the morbidly obese group had a significantly higher underlying comorbidity rate (75.6% vs.
Statistical analysis
45.8%, P＜0.001) and a higher ASA score (ASA≥2, 82.2% vs.
65.0%, P=0.017) than the normal group. However, no significant intergroup differences were found between the three groups, with respect to age, gender, or abdominal surgery history. Pathological examination revealed no significant differences in the extent of tumor invasion or lymph node metastasis between the three groups.
Operative results
Intracorporeal or extracorporeal anastomoses were performed in 522 (34.5%) and 990 (65.5%) patients, respectively. The Billroth I, Billroth II, and Roux-en Y reconstructions were performed in 829 (54.8%), 623 (41.2%), and 60 (4.0%) patients, respectively. Among all patients, 831 underwent D1+LND and 681 underwent D2 LND. Table 2 shows details of the operative results in the three obesity groups. The morbidly obese group underwent intracorporeal anastomosis more frequently (46.7% vs. 32.6%, P=0.041) than the normal group, but no significant differences were found in the 
Course of hospitalization and postoperative morbidity
Among all study subjects, the morbidity and mortality rates were 10.8% and 0.2%, respectively, and the mean length of hospital stay was 8.8±8.6 days (Table 3) . Morbidity and mortality rates in the morbidly obese group were 13.3% and 0%, respectively, and not significantly different from those in the normal group. There were no significant differences in time to first flatus or time to diet initiation between the three groups. The lengths of hospital stay were also similar between the three groups (9.0 days in the normal group, 8.4 days in the obese group, and 8.2 days in the morbidly obese group, P=0.380). Table 4 provides details of postoperative complications that occurred in the three obesity groups. Among all study subjects, the most common complication was luminal bleeding (2.1%), followed by abdominal infection (1.3%), gastric stasis (1.1%), abdominal bleeding (0.9%), and wound complications (0.8%). The rates of each complication were not significantly different between the three groups. 
Discussion
Obesity is often regarded as a challenging problem for many surgeons who perform gastric cancer operations. [17] [18] [19] Studies investigating the technical safety and feasibility of LG have been facilitated by an increasingly higher level of LG skills among surgeons. 
Based on the Accordion classification of the severity of complications.
Most of these studies have been conducted in obese patients, but the feasibility of LG in morbidly obese patients with a BMI of ≥30 kg/m 2 , has been rarely examined. In the present study, we found that morbidly obese patients had short-term surgical outcomes that were comparable to those of normal patients. Except for a longer operating time, the differences observed between morbidly obese patients and the normal BMI patients in terms of postoperative recovery, length of hospital stay, or morbidity and mortality were not significant. The present study suggests that LDG can be safely performed in morbidly obese patients and should be considered as the primary treatment option for this patient group.
An early study by Noshiro and colleagues 20 suggested that obe- and, as a result, surgeons will undoubtedly encounter a progressively greater number of morbidly obese gastric cancer patients. 21, 22 To our knowledge, only one previous study has evaluated the surgical outcomes of LDG in morbidly obese patients. Contrary to our results, the authors reported longer operating times, larger intraoperative blood losses, delay in diet initiation, longer duration of hospital stays, and more postoperative complications in morbidly obese patients undergoing LDG. 23 Considering the feasibility of LDG in morbidly obese patients may depend on the surgeon's experience in
LG and on the quality of perioperative hospital management, additional studies are necessary to address conclusively the feasibility and safety of LDG in morbidly obese patients with gastric carcinoma. Values are presented as number (%). Complication rates in the three study groups showed no statistical differences.
Some limitations deserve consideration in the present study.
First, the study was inherently limited by its retrospective design, and thus, selection bias. Bias may have resulted from a preference of inexperienced surgeons, during their initial phases of training, for patients with a lower BMI for laparoscopic surgery, which followed the selection of more obese patients as they accumulated surgical experience. Thus, this learning curve effect may have minimized the differences in surgical outcomes, such as operating time and morbidity, between groups.
LG is technically demanding in morbidly obese patients as reflected in the longer operating times, and the findings of this study may suggest that a substantial laparoscopic surgery experience is necessary for successful operative outcomes in morbidly obese patients. Second, although the present study demonstrates the feasibility of LDG in morbidly obese patients, it would be more appropriate to evaluate the value of
LG by comparing the surgical outcomes of open and LG in these patients. However, this type of analysis might be somewhat dif- ficult to undertake using a retrospective study design because of the broad variety of operative indications for open and LG.
In conclusion, the present study demonstrated the technical feasibility and safety of LDG in morbidly obese patients with gastric cancer. Despite a longer operating time, no significant differences were found between the normal and morbidly obese patients in terms of postoperative recovery, length of hospital stay, or morbidity and mortality. LDG can be safely performed in morbidly obese patients by experienced surgeons and should be considered as the primary treatment option for this patient group.
